Momenta Pharmaceuticals, Inc. (MNTA) Has Bullish Wedge Up Trading At $19.55

April 17, 2018 - By Elizabeth Jones

During 2017 Q4 the big money sentiment decreased to 1.45. That’s change of 0.28, from 2017Q3’s 1.73. 19 investors sold all, 36 reduced holdings as Momenta Pharmaceuticals, Inc. ratio turned negative. 57 increased stakes while 23 funds amassed stakes. Funds hold 71.96 million shares thus 2.47% more from 2017Q3’s 70.23 million shares.
Sector Gamma As has 0.64% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Bnp Paribas Arbitrage has 31,699 shs. Ls Advsrs Lc has invested 0.01% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Price T Rowe Assocs Md holds 0% or 1.20 million shs in its capital. Millennium Ltd Liability holds 0.01% of its capital in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) for 769,692 shs. Jpmorgan Chase has 0% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) for 781,900 shs. Point72 Asset Mgmt L P has 350,000 shs for 0.02% of their capital. Proshare Lc has invested 0.01% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Swiss Bank & Trust has 0% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) for 123,300 shs. Cornerstone Advsr has invested 0.01% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). 299,783 were accumulated by Commercial Bank Of America De. State Board Of Administration Of Florida Retirement System reported 53,502 shs. Royal Bankshares Of Canada reported 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Qs Invsts Ltd owns 184,040 shs for 0.02% of their capital. Louisiana State Employees Retirement System accumulated 32,900 shs.

Momenta Pharmaceuticals, Inc. had 12 insider sales and 0 insider buys since December 13, 2017. This’s net activity of $2.01 million. $823,346 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) was sold by WHEELER CRAIG A on Tuesday, April 10. Stoner Elizabeth sold $72,050 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) or 5,500 shs on Wednesday, December 13. On Monday, February 12 the insider Leicher Bruce sold $75,333. Kaundinya Ganesh Venkataraman had sold 4,986 shs worth $75,942 on Monday, February 12.

Momenta Pharmaceuticals, Inc. (MNTA)’s chart shows an up wedge technical pattern with $20.92 Target. That’s 7.00 % above today’s $19.55 price per share. At $20.92 stock Target, the company valuation changes by $104.86M more.

On during the last trading session the stock increased $0.1 or 0.51%, reaching $19.55.Momenta Pharmaceuticals, Inc. has volume of 369,690 shares. Since April 17, 2017 MNTA has risen 23.66% and is uptrending. MNTA outperformed the S&P 500 by 12.11%.

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Ratings Coverage

In total 2 analysts cover Momenta Pharma (NASDAQ:MNTA). “Buy” rating has 1, “Sell” are 0, while 1 are “Hold”. 50% are bullish. With $18.0 highest and $15.0 lowest [Target] Momenta Pharma has $16.50 average [Target] or -15.60% below the current ($19.55) price. 3 are the (NASDAQ:MNTA)’s analyst reports since October 31, 2017 according to StockzIntelligence Inc. On Thursday, February 22 the firm earned “Buy” rating by Stifel Nicolaus. On Tuesday, January 30 the rating was maintained by Stifel Nicolaus with “Hold”. In Tuesday, October 31 report Cowen & Co maintained it with “Hold” rating and $15.0 target.

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: